Grants and Contributions:
Title:
Postbiotic and Proteobiotic development
Agreement Number:
934635
Agreement Value:
$659,891.00
Agreement Date:
Sep 16, 2019 - Sep 30, 2021
Description:
MicroSintesis is developing novel microbiome solutions to target human and animal disease. We will investigate the use and application of natural probiotic metabolites to modulate the microbiome to improve health and wellness.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H4A 3M8
Reference Number:
172-2019-2020-Q2-934635
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
843481516
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Jul 7, 2021
Recipient's Operating Name:
MicroSintesis Inc.
Recipient's Legal Name:
MicroSintesis Inc.
Federal Riding Name:
Notre-Dame-de-Grâce--Westmount
Federal Riding Number:
24053
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: